register

Leadership & Management

J&J’s Managing Director Susan Martin discusses courage, compassion and communication on International Women’s Day

Health Industry Hub | March 9, 2021 |

Welcome to Health Industry Hub’s Women in Leadership Series – connecting, engaging and empowering women in the MedTech, Pharma and Biotech sectors by celebrating and sharing the journey of inspirational and passionate women leaders in the industry.

In continuing to celebrate International Women’s Day (IWD) 2021, Health Industry Hub‘s second interview features the former cardiac nurse and now Managing Director of Johnson & Johnson Medical Devices Australia and New Zealand, Susan Martin.

As a passionate leader in the MedTech sector, Susan sheds light on the choices made by female leaders to overcome barriers and perform at the top of their game at every level, her bravest career moment, the most important traits – courage, compassion and communication – that we need in leaders today, and what the IWD 2021 theme #ChooseToChallenge means to her.

About Susan Martin

Susan Martin has over 20 years experience in the Medical Device sector incorporating senior roles across sales, marketing, project management & people leadership. Her career journey spans incorporates global exposure with roles in Asia, ANZ and USA. Susan is passionate about sustainable healthcare, leading high-performing teams and making an impact. She is currently the Managing Director for Johnson & Johnson Medical, Australia & New Zealand.


News & Trends - Pharmaceuticals

Clinicians shift stance, join calls for PBS subsidy of obesity and weight-loss medicines

Clinicians shift stance, join calls for PBS subsidy of obesity and weight-loss medicines

Health Industry Hub | March 14, 2025 |

Over a third of Australian adults live with obesity, and the National Obesity Strategy estimates the direct and indirect costs […]

More


News & Trends - Pharmaceuticals

Astellas secures new indication for prostate cancer drug

Astellas secures new indication for prostate cancer drug

Health Industry Hub | March 14, 2025 |

Astellas Xtandi (enzalutamide) is now TGA registered for a new indication for patients with non-metastatic hormone-sensitive prostate cancer (nmHSPC) with […]

More


News & Trends - MedTech & Diagnostics

Stakeholder calls intensify as government stalls on genetic discrimination ban

Stakeholder calls intensify as government stalls on genetic discrimination ban

Health Industry Hub | March 14, 2025 |

Calls have intensified for the federal government to honour its commitment to outlaw genetic discrimination in life insurance, as stakeholders […]

More


News & Trends - MedTech & Diagnostics

Pressure mounts to expand home-based therapies in kidney disease: World Kidney Day

Pressure mounts to expand home-based therapies in kidney disease: World Kidney Day

Health Industry Hub | March 13, 2025 |

As Australia marks World Kidney Day, the stark reality is that one in three adults is at risk of chronic […]

More


This content is copyright protected. Please subscribe to gain access.